SANTOS DAVID A (EVP, Chief Commercial Officer) received a stock award from RIGEL PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2026ACC: 0000905148-26-000954
Officer· EVP, Chief Commercial Officer
Since Aug 2020
+19.43K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
19.43K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+19.43K
Price / share
—
Trade value
—
% of position
44.7%
2/17/2026
43.44K→62.87K
Total
Net shares
+19.43K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | A · Award | +19.43K | — | — | 44.7% | 43.44K | 62.87K |
| Total | +19.43K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported